Suppr超能文献

澳大利亚囚犯中患者准备情况、动机及丙型肝炎治疗接受情况的描述性模型。

A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.

作者信息

Yap Lorraine, Carruthers Susan, Thompson Sandra, Cheng Wendy, Jones Jocelyn, Simpson Paul, Richards Alun, Thein Hla-Hla, Haber Paul, Lloyd Andrew, Butler Tony

机构信息

Justice Health Research Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.

出版信息

PLoS One. 2014 Feb 27;9(2):e87564. doi: 10.1371/journal.pone.0087564. eCollection 2014.

Abstract

BACKGROUND

Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%-3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations.

METHOD AND FINDINGS

We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners.

CONCLUSION

This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.

摘要

背景

丙型肝炎病毒感染(HCV)给全球健康带来了沉重负担,估计全球有2%至3%的人口感染该病毒,每年有超过35万人死于与HCV相关的疾病,包括肝衰竭和肝癌。监狱可能提供一个相对稳定的环境来开始治疗,因为监狱通常能让囚犯方便地接触到医疗服务提供者,并且其运作围绕着常规和秩序。然而,HCV治疗在社区和监狱中的接受率仍然很低。在本研究中,我们探讨了影响监狱内治疗接受率的因素,并假设囚犯由于被监禁而存在影响HCV治疗接受率的独特问题,而这些问题在其他人群中并不存在。

方法与结果

我们进行了一项定性研究,探讨囚犯对于在监狱中拒绝、推迟、延误或停止HCV治疗的原因的描述。在2010年至2013年期间,对来自新南威尔士州、昆士兰州和西澳大利亚州监狱的116名澳大利亚囚犯进行了访谈。囚犯经历的许多因素与影响社区中HCV感染者治疗接受率的因素相似。然而,监禁提供了不同的环境来体验这些因素,如果要增加接受治疗的囚犯数量,就需要更好地理解这些环境。我们建立了一个关于监狱内HCV治疗患者准备情况和动机的描述模型,并讨论了如何提高囚犯中的治疗接受率。

结论

本研究确定了监狱中HCV治疗面临的一系列广泛且独特的挑战。其中一些挑战可能会通过改善治疗选择和改进医疗服务提供模式而减少。其他障碍与囚犯对自身疾病的理解以及其他囚犯和监管人员的污名化有关,尽管基于同伴的教育有可能解决知识缺乏和污名化问题,但这些障碍通常似乎较难改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8988/3937313/4545d803112b/pone.0087564.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验